血清RBP4、MCP-1、SAA水平变化与缺血性脑卒中老年患者NIHSS评分的相关性

Abstract
Figure/Table
References
Related Citation (11)

Download: PDF (751 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the correlations between levels of serum amyloid A protein (SAA), retinol binding protein (RBP4), monocyte chemotactic protein (MCP-1) and the NIHSS score of ischemic stroke patients.Methods Fifty cases of elderly inpatients diagnosed with acute ischemic stroke between January 2013 and January 2015 were selected as the observation group, while another 50 healthy people served as the control group. The serum levels of SAA, RBP4 and MCP-1 were compared between the two groups. According to the NIHSS scores of these patients, the observation group was divided into the mild, moderate and severe groups of neural impairment. Serum levels of MCP-1, SAA and RBP4 were compared between the three groups, so were prognosis, rates of progressive stroke and mortality.Results According to the study, serum MCP-1, SAA and RBP4 levels were higher in the observation group than in the control group, and the difference was statistically significant (P<0.05).Serum MCP-1, SAA and RBP4 levels were gradually increased in the observation group compared with the mild, moderate and severe groups, and the difference was also statistically significant (P<0.05). Serum MCP-9, SAA and RBP4 levels in the observation group were decreased considerably three, five and seven days after hospitalization compared with one day after hospitalization, and the difference was of statistical significance. There were twelve mild cases, eighteen moderate cases and twenty severe cases according to the NIHSS scores. Conclusions Serum, MCP-1, SAA and RBP4 levels of acute ischemic stroke patients are significantly increased and are positively correlated with the severity of the disease, so they can be used as laboratory indicators for the diagnosis of the disease.

Key words： acute ischemic stroke serum amyloid A protein monocyte chemotactic protein retinol binding protein NIHSS

Received: 29 March 2019

ZTFLH:

R743.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MAO Congda
	LI Lingling
	NIUZhaoqing
	and ZHANG Haimao

Cite this article:

MAO Congda,LI Lingling,NIUZhaoqing等. Correlations between serum SAA, RBP4, MCP-1 levels and NIHSS scores in patients with ischemic stroke[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 693-696.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I8/693

[1]	许云鹤,刘永刚,赵小妹,等.血清SAA、RBP4、MCP-1与缺血性脑卒中脑损伤及梗死程度的关系研究[J].临床和实验医学杂志,2018,17(3):255-258.
[2]	刘京伟,陈玲玲,赵安成.血清SAA、CRP、PCT及TAP联合检测在急性重症胰腺炎早期诊治中的临床意义[J].国际检验医学杂志,2016,37(13):1811-1813.
[3]	孟文婷,李东翔,佟玲.缺血性脑卒中的治疗研究进展[J].中国新药杂志,2016,20(10):1114-1120.
[4]	于卫兵,于宁波,滕文慧,等.血清SAA和hs-CRP与脑梗死TOAST亚型的关系[J].青岛大学医学院学报,2015,51(06):701-703,706.
[5]	王媛,张华丽,张勇.COPD急性加重期患者血清SAA、PCT、hs-CRP水平变化及意义[J].陕西医学杂志,2015,44(05):616-617.
[6]	刘晶,金香兰,郑宏,等.缺血性脑卒中患者认知功能障碍的影响因素研究[J].中国全科医学,2015,18(12):1361-1365.
[7]	董秋艳,樊丽娟,苏慧,等.急性缺血性脑卒中早期神经功能恶化的影响因素[J].武警医学,2018,29(1):21-24.
[8]	张小雪,张京芬.国内急性期缺血性脑卒中的溶栓治疗现状分析[J].中华老年心脑血管病杂志,2015,17(2):222-224.
[9]	孙亚威,尚可,刘冬青,等.血清视黄醇结合蛋白4与2型糖尿病合并代谢综合征的相关性[J].中华老年心脑血管病杂志,2014,16(2):144-146.
[10]	张曼丽,陈卫东,杨萍,等.MCP-1、ICAM-1在糖尿病肾病大鼠肾脏损害中作用及厄贝沙坦干预的影响[J].中国中西医结合肾病杂志,2013,14(12):1040-1043.
[11]	苏雪.缺血性脑卒中患者血清UA、Hcy、ApoB/ApoA1水平与疾病发生及神经功能缺损程度评分的关系[J].卒中与神经疾病,2019(2):214-216.
[12]	张佳琪,王迪,朱雨岚.血管内皮生长因子与缺血性脑卒中的研究进展[J].中华老年心脑血管病杂志,2019,21(4):446-448.
[13]	钱铭净,张东伟.肾小球滤过率预测急性非心源性缺血性脑卒中复发和死亡的临床价值[J].心电与循环,2019,38(02):110-114.
[14]	马蓉,徐弘杨,王光明.缺血性脑卒中的血液学标志物研究进展[J].检验医学与临床,2019,16(6):853-856.
[15]	李华坚.缺血性脑卒中早期神经功能恶化的危险因素分析[J/OL].中西医结合心脑血管病杂志,2018,14(22):3376-3378.
[16]	王梓晗,邓剑平,李淑敏,等.急性缺血性脑卒中患者血清CXCL12、IL-33表达水平及临床意义[J].人民军医,2018,46(12):1448-1449.